StockData
Cresco Labs Inc. logo

Cresco Labs Inc. (CRLBF) stock

CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Cresco Labs operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$27.99M, down 126.1% from the year before. The highest annual figure on record is $107.29M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.99M-126.1%
FY2024Dec 31, 2024$107.29M–
FY2023Dec 31, 2023-$87.82M–
FY2022Dec 31, 2022-$84.30M–
FY2021Dec 31, 2021-$217.35M–
FY2020Dec 31, 2020-$23.46M–
FY2019Dec 31, 2019-$34.26M–

More Cresco Labs figures

See a number that looks wrong?